Trial intelligence / Profile preview

Limbal epithelial stem cell transplantation for LSCD

NCT02318485Phase 2Completed

Start
Apr 2015
Primary completion
Jan 2023
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of Limbal epithelial stem cell graft in limbal stem cell deficiency (LSCD). Started Apr 2015; status: completed.

02

Drugs

Limbal epithelial stem cell graft
03

Conditions

limbal stem cell deficiency (LSCD)

Beyond the preview

Go deeper on NCT02318485.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02318485.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call